Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes

…, M Zrein, S Van Gucht, MN Schmickler… - medRxiv, 2021 - medrxiv.org
Background Residents of nursing homes (NH) are at high risk of COVID-19 related morbidity
and death and may respond poorly to vaccination because of old age and frequent …

Global infectious disease risks associated with occupational exposure among non-healthcare workers: a systematic review of the literature

…, S Couvreur, WM Bramer, MN Schmickler… - Occupational and …, 2022 - oem.bmj.com
Objectives Employees in non-healthcare occupations may be in several ways exposed to
infectious agents. Improved knowledge about the risks is needed to identify opportunities to …

Poor antibody response to BioNTech/Pfizer coronavirus disease 2019 vaccination in severe acute respiratory syndrome coronavirus 2–naive residents of nursing …

…, M Zrein, S Van Gucht, MN Schmickler… - Clinical Infectious …, 2022 - academic.oup.com
Background Residents of nursing homes (NHs) are at high risk of coronavirus disease 2019
(COVID-19)–related disease and death and may respond poorly to vaccination because of …

[HTML][HTML] The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff-study protocol description and presentation of preliminary findings on …

…, I Thomas, SV Gucht, K Dierick, MN Schmickler… - Archives of Public …, 2021 - Springer
Background The COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns …

[HTML][HTML] Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults

…, E Willems, E Dhondt, M Krauchuk, MN Schmickler… - Vaccine, 2023 - Elsevier
Background Nursing home residents, a frail and old population group, respond poorly to
primary mRNA COVID-19 vaccination. A third dose has been shown to boost protection against …

[HTML][HTML] Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

…, M Verbrugghe, MN Schmickler… - PLOS global public …, 2022 - journals.plos.org
Fractional dosing of COVID-19 vaccines could accelerate vaccination rates in low-income
countries. Dose-finding studies of the mRNA vaccine BNT162b2 (Pfizer-BioNTech) suggest …

Investing in workability of patients with inflammatory bowel disease: results of a pilot project Activ84worK (Activate for work)

S Coenen, MN Schmickler, D Staes… - European Journal of …, 2019 - journals.lww.com
Objectives Inflammatory bowel diseases (IBD) are chronic gastrointestinal conditions mainly
affecting young people. Disease symptoms often make it difficult to actively participate in the …

S-81 Infectious disease risks associated with occupational exposure among non-healthcare workers: a systematic review of the literature

…, J Haagsma, S Couvreur, W Bramer, MN Schmickler - 2021 - oem.bmj.com
Objective The purpose of this systematic review is to provide an overview of the published
evidence on the role of infectious diseases in occupational health, focusing on occupations …

Outlining the Prior Infection with SARS-CoV-2 study (PICOV)-preliminary findings on symptoms in nursing home residents and staff.

…, I Thomas, S Van Gucht, K Dierick, MN Schmickler… - 2021 - researchsquare.com
Background: COVID-19 has presented itself as one of the most important health concerns of
2020. The geriatric population is arguably hit the hardest by the severe acute respiratory …

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes (preprint)

…, M Zrein, S Van Gucht, MN Schmickler… - 2021 - pesquisa.bvsalud.org
Background Residents of nursing homes (NH) are at high risk of COVID-19 related morbidity
and death and may respond poorly to vaccination because of old age and frequent …